179 related articles for article (PubMed ID: 30501144)
1. Immunohistochemical Analysis of LGR5 and TROY Expression in Gastric Carcinogenesis Demonstrates an Inverse Trend.
Saberi S; Piryaei A; Mirabzadeh E; Esmaeili M; Karimi T; Momtaz S; Abdirad A; Sodeifi N; Mohagheghi MA; Baharvand H; Mohammadi M
Iran Biomed J; 2019 Mar; 23(2):107-20. PubMed ID: 30501144
[TBL] [Abstract][Full Text] [Related]
2. Troy, a tumor necrosis factor receptor family member, interacts with lgr5 to inhibit wnt signaling in intestinal stem cells.
Fafilek B; Krausova M; Vojtechova M; Pospichalova V; Tumova L; Sloncova E; Huranova M; Stancikova J; Hlavata A; Svec J; Sedlacek R; Luksan O; Oliverius M; Voska L; Jirsa M; Paces J; Kolar M; Krivjanska M; Klimesova K; Tlaskalova-Hogenova H; Korinek V
Gastroenterology; 2013 Feb; 144(2):381-391. PubMed ID: 23142137
[TBL] [Abstract][Full Text] [Related]
3. Expression of LGR5, FZD7, TROY, and MIST1 in Perioperatively Treated Gastric Carcinomas and Correlation with Therapy Response.
Freiin Grote A; Halske C; Behrens HM; Krüger S; Wilhelm F; Egberts JH; Röcken C
Dis Markers; 2019; 2019():8154926. PubMed ID: 31827644
[TBL] [Abstract][Full Text] [Related]
4. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
[TBL] [Abstract][Full Text] [Related]
5. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
6. H. pylori infection is associated with DNA damage of Lgr5-positive epithelial stem cells in the stomach of patients with gastric cancer.
Uehara T; Ma D; Yao Y; Lynch JP; Morales K; Ziober A; Feldman M; Ota H; Sepulveda AR
Dig Dis Sci; 2013 Jan; 58(1):140-9. PubMed ID: 22945475
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
Jang BG; Lee BL; Kim WH
Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
[TBL] [Abstract][Full Text] [Related]
8. Leucine-rich repeat-containing G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer.
Xi HQ; Cai AZ; Wu XS; Cui JX; Shen WS; Bian SB; Wang N; Li JY; Lu CR; Song Z; Wei B; Chen L
Br J Cancer; 2014 Apr; 110(8):2011-20. PubMed ID: 24594994
[TBL] [Abstract][Full Text] [Related]
9. Lgr5 Contributes to Intestinal Metaplasia During Gastric Carcinogenesis: A Meta analysis.
Han Y; Zhi Q; Xue X; Yuan B; Zhao H; Kuang Y; Zhang L
Anticancer Agents Med Chem; 2016; 16(9):1079-84. PubMed ID: 26077638
[TBL] [Abstract][Full Text] [Related]
10. Lgr5 expression as stem cell marker in human gastric gland and its relatedness with other putative cancer stem cell markers.
Wu C; Xie Y; Gao F; Wang Y; Guo Y; Tian H; Li Y; Fan W
Gene; 2013 Aug; 525(1):18-25. PubMed ID: 23664892
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori Activates and Expands Lgr5(+) Stem Cells Through Direct Colonization of the Gastric Glands.
Sigal M; Rothenberg ME; Logan CY; Lee JY; Honaker RW; Cooper RL; Passarelli B; Camorlinga M; Bouley DM; Alvarez G; Nusse R; Torres J; Amieva MR
Gastroenterology; 2015 Jun; 148(7):1392-404.e21. PubMed ID: 25725293
[TBL] [Abstract][Full Text] [Related]
12. FOXO1 reduces tumorsphere formation capacity and has crosstalk with LGR5 signaling in gastric cancer cells.
Choi Y; Park J; Ko YS; Kim Y; Pyo JS; Jang BG; Kim MA; Lee JS; Chang MS; Lee BL
Biochem Biophys Res Commun; 2017 Nov; 493(3):1349-1355. PubMed ID: 28970066
[TBL] [Abstract][Full Text] [Related]
13. Distribution of Lgr5-positive cancer cells in intramucosal gastric signet-ring cell carcinoma.
Nakajima T; Uehara T; Maruyama Y; Iwaya M; Kobayashi Y; Ota H
Pathol Int; 2016 Sep; 66(9):518-23. PubMed ID: 27593551
[TBL] [Abstract][Full Text] [Related]
14. Upregulated miR-132 in Lgr5
Zhang L; Guo X; Zhang D; Fan Y; Qin L; Dong S; Zhang L
Mol Carcinog; 2017 Sep; 56(9):2022-2034. PubMed ID: 28383763
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor receptor superfamily member TROY is a novel melanoma biomarker and potential therapeutic target.
Spanjaard RA; Whren KM; Graves C; Bhawan J
Int J Cancer; 2007 Mar; 120(6):1304-10. PubMed ID: 17187358
[TBL] [Abstract][Full Text] [Related]
16. Correlation of Musashi-1, Lgr5, and pEGFR expressions in human small intestinal adenocarcinomas.
Wang Y; Jiang CQ; Fan LF
Tumour Biol; 2015 Aug; 36(8):6075-82. PubMed ID: 25773390
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T Cells Promote Overexpression of Lgr5 on Gastric Cancer Cells via TGF-beta1 and Confer Poor Prognosis in Gastric Cancer.
Liu XS; Lin XK; Mei Y; Ahmad S; Yan CX; Jin HL; Yu H; Chen C; Lin CZ; Yu JR
Front Immunol; 2019; 10():1741. PubMed ID: 31417548
[No Abstract] [Full Text] [Related]
18. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J
J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924
[TBL] [Abstract][Full Text] [Related]
19. Novel Insights into Gastric Cancer: Methylation of R-spondins and Regulation of LGR5 by SP1.
Wilhelm F; Simon E; Böger C; Behrens HM; Krüger S; Röcken C
Mol Cancer Res; 2017 Jun; 15(6):776-785. PubMed ID: 28219935
[TBL] [Abstract][Full Text] [Related]
20. RNAi-mediated inhibition of Lgr5 leads to decreased angiogenesis in gastric cancer.
Xi HQ; Zhang KC; Li JY; Cui JX; Gao YH; Wei B; Huang D; Chen L
Oncotarget; 2017 May; 8(19):31581-31591. PubMed ID: 28404940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
